Centus Settles US Litigation Over Avastin
Agrees To Resolve Bevacizumab Patent Case With Genentech
Centus Biotherapeutics and Roche’s Genentech have agreed to settle US patent litigation over the biosimilars firm’s FKB238 proposed bevacizumab rival to Avastin.
